본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Cancer statistics in Korea : incidence, mortality, survival, and prevalence in 2023 Eun Hye Park, Kyu-Won Jung, Seo Hyun Choi, Nam Ju Park, Mee Joo Kang, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Kui Son Choi, Han-Kwang Yang, Community of Population-Based Regional Cancer Registries p. 349-367
Prediction of cancer incidence and mortality in Korea, 2026 Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Kui Son Choi, Han-Kwang Yang p. 368-375
IARC group 1 pharmaceuticals and associated cancer risks : a nationwide population-based cohort study in Korea Woojin Lim, Na Rae Lee, Ho Gyun Shin, Su-Yeon Yu, Sue K. Park p. 376-392
Awareness and practice of dietary recommendations for cancer prevention among participants of the 2023 Korean National Cancer Prevention for Dietary Awareness and Practice Survey Yoonjoo Choi, Hyein Jung, Byungmi Kim p. 393-406
DNA damage and nuclear anaplasia induced by trastuzumab deruxtecan in cancer cells with variable HER2 expression and homologous recombination deficiency status So Hyeon Kim, Yoonjung Park, Ahrum Min, Hye Yeon Park, Yu-Jin Kim, Sujin Ham, Jiwon Koh, Seongyeong Kim, Dae-Won Lee, Han Suk Ryu, Jin-Soo Kim, Kyung-Hun Lee, Seock-Ah Im p. 407-422
NOVA1 activation modulates the tumor immune microenvironment through STING phosphorylation in head and neck squamous cell carcinoma Sehui Kim, Hyang Mi Kim, Jae Min Bae, Sun Och Yoon p. 423-433
Clinical relevance of starting alectinib at a reduced dose in patients with ALK-positive non–small cell lung cancer Junkyu Kim, Min-Ji Kim, Jinyong Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jong-Mu Sun p. 434-442
Trends and outcomes of lung cancer surgery in South Korea Joon Beom Park, Su-Jin Cho, Myung-Il Hahm, Danbee Kang, Seong Yong Park p. 443-453
Comparison of surveillance with low-dose and contrast-enhanced chest computed tomography in patients disease-free for 2 years after curative resection for lung cancer Bubse Na, Ji Hyeon Park, Kwon Joong Na, Samina Park, Chang Hyun Kang, Young Tae Kim, In Kyu Park p. 454-464
Anticancer treatment influences TREM2 in tumor-associated macrophages in lung cancer Yoon Jin Cha, Eun Hye Lee, Chi Young Kim, Yong Jun Choi, Min Kyung Park, Sang Hoon Lee, Eun Young Kim, Yoon Soo Chang p. 465-480
Secondary cancer risk in breast cancer with and without radiotherapy : the Observational Health Data Sciences and Informatics (OHDSI) cohort study Seok Kim, Dachung Boo, Sooyoung Yoo, Borham Kim, Kyubo Kim, Kwangsoo Kim, Eunhye Song, Junmo Kim, Hyun Gee Ryoo, Jin Chul Paeng, In Young Choi, SooJeong Ko, Ie Ryung Yoo, Rae Woong Park, Ho-Young Lee p. 481-491
Comparative study of mastectomy using conventional techniques, multiport and single-port robotic surgical systems Jeea Lee, Jieon Go, Suk Jun Lee, Yonghan Kwon, Nam Hee Kim, Jee Ye Kim, Hyung Seok Park p. 492-500
Differences in responses to neoadjuvant anti-HER2 therapy between HER2 2+/ISH+ and HER2 3+ in HER2-positive breast cancer Lingjun Ma, Ran Zheng, Lingyun Xu, Ying Zhu, Hong Yin, Xiaoqing Zhang, Rong Deng, Jue Wang, Xiaoming Zha p. 501-512
Safety and effectiveness of eribulin in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes in real-world clinical practice : a 6-year post-marketing surveillance study in South Korea Yee Soo Chae, Kyung A Kwon, Moon Hee Lee, Mi Sun Ahn, Kyung-Hun Lee, Su-Jin Koh, Joohyuk Sohn, Keon Uk Park, Min Young Kim, Youngji Pyo, Bo Young Kim, Kyung Hae Jung p. 513-524
Sex disparities in breast cancer survival according to clinical treatment score post-5 years (CTS5) risk stratification Ke Liu, Zhen-Zhen Lu, Zhen-Yu He, San-Gang Wu p. 525-533
Radiation-associated heart disease in Korean women after radiotherapy for breast cancer : insights from the National Health Insurance Service database Jun-Hyuk Lee, Jimin Park, Tae Hyung Kim p. 534-543
RASSF4 suppresses gastric tumor growth through activation of Chk2-p53 signaling axis Soon-Ki Park, Min-Ju Kang, Kyung-Phil Ko, Sung-Gil Chi p. 544-562
Discrepancy between genetically predicted and observed alcohol intake and its impact on gastric cancer susceptibility Ga-Eun Yie, Cheol Min Shin, Kyungtaek Park, Jinyeon Jo, Ah Ra Do, Sungkyoung Choi, Jung Hun Ohn, Sejoon Lee, Jeongseon Kim, Sun Ha Jee, Seung Joo Kang, Nayoung Kim, Sungho Won p. 563-572
Non-operative management of rectal cancer with adjuvant chemotherapy after chemoradiotherapy (NORMANDY) : prospective study Hyebin Lee, Hyung Ook Kim, Jason Joon Bock Lee, In-Gu Do, Heon-Ju Kwon, Mi Sung Kim, Soo-Kyung Park, Hyo-Joon Yang, Yoon Suk Jung, Jung Ho Park ... [et al.] p. 573-580
Neoadjuvant sintilimab combined with gemcitabine and cisplatin for muscle-invasive bladder cancer patients followed by selective bladder sparing surgery : a phase 2 trial Zhou Tong, Guanghou Fu, Feng Zhou, Xiaoyan Liu, Xing Xue, Hangyu Zhang, Yimin Wang, Xudong Zhu, Yang Gao, Lulu Liu, Xuanwen Bao, Yi Zheng, Weijia Fang, Peng Zhao, Baiye Jin p. 581-590
Real-world efficacy of intravesical gemcitabine for BCG-unresponsive non–muscle-invasive bladder cancer Hye Won Lee, Eui Hyun Jung, Kyung Hwan Kim, Hong Koo Ha, Jong Jin Oh, Seok Ho Kang, Seung-hwan Jeong, Hyeong Dong Yuk, Ji Eun Heo, Won Sik Ham ... [et al.] p. 591-602
Efficacy and safety of ifosfamide and mesna in metastatic castration-resistant prostate cancer after taxane-based chemotherapy and novel hormonal therapy failure Chang Gon Kim, Yeo Gyeong Ko, Jongjin Yoon, Chung Lee, Seung Hoon Beom, Young-Deuk Choi, Woong Kyu Han, Won Sik Ham, Hyunho Han, Jongsoo Lee ... [et al.] p. 603-612
Adjuvant pembrolizumab versus placebo for renal cell carcinoma in the East Asian subgroup of the phase 3 KEYNOTE-564 study Se Hoon Park, Yen-Hwa Chang, Jae Lyun Lee, Toni K. Choueiri, Go Kimura, Jinsoo Chung, Naoya Masumori, Kazuo Nishimura, Minoru Kato, Haruaki Kato ... [et al.] p. 613-621
Programmed death-ligand 1 expression across multiple assays in ovarian cancer : a comparative analysis Eun Bi Jang, Kyeong A So, Wook Youn Kim, So Dug Lim, Tae Jin Kim, Heejin Bang, Wan Seop Kim p. 622-631
Allogeneic hematopoietic stem cell transplantation in pediatric and young adult patients with chronic myeloid leukemia in tyrosine kinase inhibitor era : a study of the Korean Blood and Marrow Transplantation Registry Hee Young Ju, Hyoung Soo Choi, Hyeon Jin Park, Keon Hee Yoo, Chuhl Joo Lyu, Ho Joon Im, Min Kyoung Kim, Yeung-Chul Mun, Joon Ho Moon, Sung-Soo Yoon ... [et al.] p. 632-641
Malignant hepatocellular neoplasm, not otherwise specified, displays poorer chemoresponsiveness and postoperative prognosis than hepatoblastoma In Hye Song, Sujin Gang, Hee Mang Yoon, Pyeong Hwa Kim, Bokyung Ahn, Jihun Kim, Deok Hoon Kim, Jung-Man Namgoong, Kyung-Nam Koh p. 642-655
Prognostic landscape of TP53 mutations in hematologic malignancies Seo Yoon Jang, Joowon Jang, Jee-Soo Lee, Moon-Woo Seong, Songyi Park, Ja Min Byun, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Dong-Yeop Shin p. 656-663
Uncovering putative causal non-coding RNAs in acute and chronic myeloid leukemia : a genome-wide mendelian randomization study Sunwoo Jung, Ji-Won Kim, Buhm Han p. 664-676
Association between obesity and melanoma risk in an Asian population : a nationwide cohort study Hye Yeon Koo, Kyungdo Han, Jihye Park, Jinhyung Jung, Seonghye Kim, Hyeonjin Cho, In Young Cho, Dong Wook Shin p. 677-685
Insomnia, pain, and pain-related dysfunctional beliefs about sleep among patients with cancer Seockhoon Chung, Soobeen Lee, Mohd. Ashik Shahrier, Saebom Jeon p. 686-693